Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Pediatr Hematol Oncol ; 40(4): 315-325, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-35833695

RESUMO

Iron overload may contribute to long-term complications in childhood cancer survivors. There are limited reports of assessment of tissue iron overload in childhood leukemia by magnetic resonance imaging (MRI). A cross-sectional, observational study in children treated for hematological malignancy was undertaken. Patients ≥6 months from the end of therapy who had received ≥5 red-cell transfusions were included. Iron overload was estimated by serum ferritin (SF) and T2*MRI. Forty-five survivors were enrolled among 431 treated for hematological malignancies. The median age at diagnosis was 7-years. A median of 8 red-cell units was transfused. The median duration from the end of treatment was 15 months. An elevated SF (>1,000 ng/ml), elevated liver iron concentration (LIC) and myocardial iron concentration (MIC) were observed in 5 (11.1%), 20 (45.4%), and 2 (4.5%) patients, respectively. All survivors with SF >1,000 ng/ml had elevated LIC. The LIC correlated with SF (p < 0.001). MIC lacked correlation with SF or LIC. Factors including the number of red-cell units transfused and duration from the last transfusion were associated with elevated SF (p = 0.001, 0.002) and elevated LIC (p = 0.012, 0.005) in multiple linear regression. SF >595 ng/ml predicted elevated LIC with a sensitivity of 85% and specificity of 91.6% (AUC 91.2%). A cutoff >9 units of red cell transfusions had poor sensitivity and specificity of 70% and 75% (AUC 76.6%) to predict abnormal LIC. SF >600 ng/ml is a robust tool to predict iron overload, and T2*MRI should be considered in childhood cancer survivors with SF exceeding 600 ng/ml.


Assuntos
Neoplasias Hematológicas , Sobrecarga de Ferro , Humanos , Criança , Ferritinas , Estudos Transversais , Fígado/metabolismo , Sobrecarga de Ferro/diagnóstico por imagem , Sobrecarga de Ferro/etiologia , Ferro/metabolismo , Neoplasias Hematológicas/terapia , Neoplasias Hematológicas/patologia , Imageamento por Ressonância Magnética/efeitos adversos
3.
Pediatr Hematol Oncol ; 40(2): 117-130, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35849424

RESUMO

Data on childhood acute promyelocytic leukemia (APL) from low-and middle-income countries is limited. Early mortality is a concern and often not highlighted in clinical trials. The retrospective study was conducted on patients (≤12 years) with APL from 2003 to 2021 at a single center in India. Patients were treated with all-trans-retinoic acid (ATRA) and chemotherapy. Induction and three courses of consolidation were followed by maintenance for 2 years. In 2015, the protocol was updated with following modifications: (a) obtaining diagnostic cerebrospinal fluid at end-of-induction rather than at diagnosis, (b) administering intrathecal cytarabine regardless of risk-category, (c) risk-stratified administration of chemotherapy, and (d) inclusion of ATRA in all the cycles of consolidation. Sixty-two patients were diagnosed over the 17 years. The median age was 8 years (range: 0.9-12). Half had high-risk disease. Differentiation syndrome was observed in 32%, none being fatal. Eighteen (29%) patients died due to hemorrhage (83%) or septicemia (17%). Thirteen (21%) had early mortality (≤15 days), all due to hemorrhage. A platelet count <20 × 109/L predicted early mortality (odds ratio: 4.5; 95% CI: 0.9-22, p = 0.06). Treatment abandonment reduced from 23.5% during 2003-2015 to nil during 2015-2021 (p = 0.006). Three (8%) patients relapsed. The 4-year OS of all patients and the patients who survived >15 days was 70.1% and 89.6%, respectively. The 4-year EFS, including abandonment and early mortality, before and following updated protocol, was 61.4% and 65.5%, respectively (p = 0.77). Early mortality continues to be a barrier to an otherwise excellent survival in childhood APL. A significant reduction in treatment abandonment in recent years is gratifying.


Assuntos
Leucemia Promielocítica Aguda , Humanos , Lactente , Pré-Escolar , Criança , Leucemia Promielocítica Aguda/tratamento farmacológico , Estudos Retrospectivos , Tretinoína/uso terapêutico , Tretinoína/efeitos adversos , Citarabina/uso terapêutico , Hemorragia/etiologia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Resultado do Tratamento
4.
Indian J Pathol Microbiol ; 61(2): 201-203, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29676357

RESUMO

BACKGROUND: Lumbar puncture (LP) is frequently performed in patients with advanced intraocular retinoblastoma. However, this may not be necessary in a significant proportion of patients. MATERIALS AND METHODS:: A file review of patients who were diagnosed with retinoblastoma over a 13-year-period was performed. Patients who underwent LP as part of staging were included in the study. RESULTS: The study included 223 patients. One-third had bilateral retinoblastoma. The grouping was C, D, and E in 4 (2.9%), 41 (29.9%), and 92 (67.2%) patients, respectively. The stage was 0, I, II, III, and IV in 14 (6.3), 123 (55.2%), 13 (5.8%), 70 (31.4%), and 3 (1.3%) patients, respectively. Eight (3.6%) patients had a positive cerebrospinal fluid (CSF) cytology. None of the patients with intraocular disease and 7 (10%) patients with extraocular disease had a positive CSF. CONCLUSIONS: A diagnostic CSF is not indicated in patients with intraocular retinoblastoma.


Assuntos
Neoplasias da Retina/diagnóstico , Retinoblastoma/diagnóstico , Punção Espinal/métodos , Criança , Pré-Escolar , Humanos , Lactente , Estadiamento de Neoplasias , Neoplasias da Retina/patologia , Retinoblastoma/patologia , Estudos Retrospectivos , Medula Espinal/patologia
6.
J Pediatr Hematol Oncol ; 40(5): e327-e329, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-28859047

RESUMO

BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is very rarely diagnosed in children with less than 50 cases in the literature. OBSERVATION: We report a case of childhood BPDCN who mimicked acute rheumatic fever at presentation. Majority of the reported childhood BPDCN received acute lymphoblastic leukemia-like chemotherapy with/without stem cell therapy, whereas those who received acute myeloid leukemia-like therapy predominantly succumbed to disease or sepsis. Overall 68% of the patients were alive and achieved complete remission with an overall prognosis slightly better in children compared with adults. CONCLUSIONS: The case is reported due to its unique unusual clinical presentation and its rarity in pediatric population.


Assuntos
Antineoplásicos/administração & dosagem , Células Dendríticas , Neoplasias Hematológicas/diagnóstico , Neoplasias Hematológicas/terapia , Febre Reumática/diagnóstico , Febre Reumática/terapia , Transplante de Células-Tronco , Aloenxertos , Criança , Diagnóstico Diferencial , Feminino , Humanos
7.
J Pediatr Hematol Oncol ; 39(4): 309-310, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28060119

RESUMO

BACKGROUND: Malignancy is the most common etiology of acquired fistulae between the tracheobronchial tree and esophagus. The majority are due to either primary bronchial or esophageal carcinoma, and are typically observed in adult population. The occurrence of tracheoesophageal fistula (TEF) in patients with Hodgkin lymphoma is a rare phenomenon. OBSERVATION: We report a rare case of Hodgkin lymphoma with TEF in a 10-year-old girl at presentation. She also developed pulmonary tuberculosis later during the follow up. She was fed through a nasogastric tube to avoid aspiration through the fistulous tract. She did well with chemotherapy and anti-tubercular therapy. CONCLUSIONS: Our case suggests TEF in Hodgkin lymphoma at the time of diagnosis is a rare complication in pediatric age group. Lymphoma-related TEF require far less active intervention, as against esophageal or bronchial malignancy related TEF.


Assuntos
Doença de Hodgkin/complicações , Fístula Traqueoesofágica/diagnóstico , Antineoplásicos/uso terapêutico , Antituberculosos/uso terapêutico , Criança , Feminino , Doença de Hodgkin/tratamento farmacológico , Humanos , Fístula Traqueoesofágica/tratamento farmacológico , Fístula Traqueoesofágica/etiologia , Resultado do Tratamento , Tuberculose Pulmonar/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA